<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>TTDs | Blood Bank</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="While modern blood banking practices have made the blood supply incredibly safe, especially in developed countries, the risk of Transfusion-Transmitted Diseases (TTDs), although very low, can...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="TTDs | Blood Bank">
<meta property="og:type" content="book">
<meta property="og:description" content="While modern blood banking practices have made the blood supply incredibly safe, especially in developed countries, the risk of Transfusion-Transmitted Diseases (TTDs), although very low, can...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="TTDs | Blood Bank">
<meta name="twitter:description" content="While modern blood banking practices have made the blood supply incredibly safe, especially in developed countries, the risk of Transfusion-Transmitted Diseases (TTDs), although very low, can...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
<link rel="stylesheet" href="toc.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Blood Bank</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Blood Products</li>
<li><a class="" href="donors.html">Donors</a></li>
<li><a class="" href="qualification.html">Qualification</a></li>
<li><a class="" href="processing.html">Processing</a></li>
<li><a class="" href="adverse-reactions-1.html">Adverse Reactions</a></li>
<li><a class="" href="special-donations-1.html">Special Donations</a></li>
<li><a class="" href="processing-1.html">Processing</a></li>
<li><a class="" href="fda-aabb-requirements.html">FDA, AABB Requirements</a></li>
<li><a class="" href="testing.html">Testing</a></li>
<li><a class="" href="labeling.html">Labeling</a></li>
<li><a class="" href="storage.html">Storage</a></li>
<li><a class="" href="anticoagulantsadditives.html">Anticoagulants/Additives</a></li>
<li><a class="" href="temperature-requirements.html">Temperature Requirements</a></li>
<li><a class="" href="transportation.html">Transportation</a></li>
<li><a class="" href="stored-products.html">Stored Products</a></li>
<li><a class="" href="expiration.html">Expiration</a></li>
<li><a class="" href="blood-components.html">Blood Components</a></li>
<li><a class="" href="red-blood-cells.html">Red Blood Cells</a></li>
<li><a class="" href="cryoprecipitated-ahf.html">Cryoprecipitated AHF</a></li>
<li><a class="" href="platelets.html">Platelets</a></li>
<li><a class="" href="plasma.html">Plasma</a></li>
<li><a class="" href="granulocytes.html">Granulocytes</a></li>
<li><a class="" href="wbc-reduced-components.html">WBC-Reduced Components</a></li>
<li><a class="" href="frozendeglycerolized-rbcs.html">Frozen/Deglycerolized RBCs</a></li>
<li><a class="" href="apheresis-products.html">Apheresis Products</a></li>
<li><a class="" href="fractionation-products.html">Fractionation Products</a></li>
<li><a class="" href="whole-blood.html">Whole Blood</a></li>
<li><a class="" href="washed-rbcs.html">Washed RBCs</a></li>
<li><a class="" href="rejuvenated-rbcs.html">Rejuvenated RBCs</a></li>
<li><a class="" href="irradiated-components.html">Irradiated Components</a></li>
<li><a class="" href="hematopoietic-progenitors.html">Hematopoietic Progenitors</a></li>
<li><a class="" href="blood-component-qc.html">Blood Component QC</a></li>
<li class="book-part">Blood Group Systems</li>
<li><a class="" href="genetics.html">Genetics</a></li>
<li><a class="" href="basic.html">Basic</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="blood-group-inheritance.html">Blood Group Inheritance</a></li>
<li><a class="" href="biochemistryantigens.html">Biochemistry/Antigens</a></li>
<li><a class="" href="abo.html">ABO</a></li>
<li><a class="" href="lewis.html">Lewis</a></li>
<li><a class="" href="rh.html">Rh</a></li>
<li><a class="" href="mns.html">MNS</a></li>
<li><a class="" href="p1pkglobosidep.html">P1PK/Globoside(P)</a></li>
<li><a class="" href="ii.html">Ii</a></li>
<li><a class="" href="kell.html">Kell</a></li>
<li><a class="" href="kidd.html">Kidd</a></li>
<li><a class="" href="duffy.html">Duffy</a></li>
<li><a class="" href="lutheran.html">Lutheran</a></li>
<li><a class="" href="other-blood-groups.html">Other Blood Groups</a></li>
<li><a class="" href="high-prevalence-antigens.html">High Prevalence Antigens</a></li>
<li><a class="" href="low-prevalence-antigens.html">Low Prevalence Antigens</a></li>
<li><a class="" href="hla.html">HLA</a></li>
<li><a class="" href="platelet-specific.html">Platelet-Specific</a></li>
<li><a class="" href="granulocyte-specific.html">Granulocyte-Specific</a></li>
<li><a class="" href="role-of-blood-groups-in-transfusion.html">Role of Blood Groups in Transfusion</a></li>
<li><a class="" href="immunogenicity.html">Immunogenicity</a></li>
<li><a class="" href="antigen-prevalence.html">Antigen Prevalence</a></li>
<li class="book-part">Immunology &amp; Physiology</li>
<li><a class="" href="immunology.html">Immunology</a></li>
<li><a class="" href="immune-response.html">Immune response</a></li>
<li><a class="" href="primary-secondary.html">Primary &amp; Secondary</a></li>
<li><a class="" href="b-t-cells-macrophages.html">B &amp; T cells, Macrophages</a></li>
<li><a class="" href="genetics-1.html">Genetics</a></li>
<li><a class="" href="immunoglobulins.html">Immunoglobulins</a></li>
<li><a class="" href="classes-subclasses.html">Classes &amp; Subclasses</a></li>
<li><a class="" href="structure.html">Structure</a></li>
<li><a class="" href="properties.html">Properties</a></li>
<li><a class="" href="ag-ab-interactions.html">Ag-Ab Interactions</a></li>
<li><a class="" href="principles.html">Principles</a></li>
<li><a class="" href="testing-1.html">Testing</a></li>
<li><a class="" href="complement.html">Complement</a></li>
<li><a class="" href="pathway-mechanisms.html">Pathway Mechanisms</a></li>
<li><a class="" href="biologic-properties.html">Biologic Properties</a></li>
<li><a class="" href="physiology-pathophysiology.html">Physiology &amp; Pathophysiology</a></li>
<li><a class="" href="blood-physiology.html">Blood Physiology</a></li>
<li><a class="" href="circulation-volume.html">Circulation &amp; Volume</a></li>
<li><a class="" href="composition-function.html">Composition &amp; Function</a></li>
<li><a class="" href="cell-survival.html">Cell Survival</a></li>
<li><a class="" href="cell-metabolism.html">Cell Metabolism</a></li>
<li><a class="" href="hemostasis-coagulation.html">Hemostasis &amp; Coagulation</a></li>
<li><a class="" href="factors-disorders.html">Factors &amp; Disorders</a></li>
<li><a class="" href="plt-functions-disorders.html">PLT Functions &amp; Disorders</a></li>
<li><a class="" href="hdfn.html">HDFN</a></li>
<li><a class="" href="pathophysiology.html">Pathophysiology</a></li>
<li><a class="" href="detection.html">Detection</a></li>
<li><a class="" href="treatment.html">Treatment</a></li>
<li><a class="" href="prevention.html">Prevention</a></li>
<li><a class="" href="cytopenias-1.html">Cytopenias</a></li>
<li><a class="" href="anemia.html">Anemia</a></li>
<li><a class="" href="thrombocytopenia.html">Thrombocytopenia</a></li>
<li><a class="" href="neutropenia.html">Neutropenia</a></li>
<li><a class="" href="transplantation-1.html">Transplantation</a></li>
<li><a class="" href="solid-organ.html">Solid Organ</a></li>
<li><a class="" href="hpc.html">HPC</a></li>
<li class="book-part">Serology &amp; Molecular</li>
<li><a class="" href="routine-tests.html">Routine Tests</a></li>
<li><a class="" href="blood-grouping.html">Blood Grouping</a></li>
<li><a class="" href="compatibility.html">Compatibility</a></li>
<li><a class="" href="antibody-detection.html">Antibody Detection</a></li>
<li><a class="" href="crossmatch.html">Crossmatch</a></li>
<li><a class="" href="ab-id-significance.html">Ab ID &amp; Significance</a></li>
<li><a class="" href="dat.html">DAT</a></li>
<li><a class="" href="reagents.html">Reagents</a></li>
<li><a class="" href="antiglobulin-sera.html">Antiglobulin Sera</a></li>
<li><a class="" href="blood-grouping-sera.html">Blood Grouping Sera</a></li>
<li><a class="" href="reagent-rbcs.html">Reagent RBCs</a></li>
<li><a class="" href="special-tests-reagents.html">Special Tests &amp; Reagents</a></li>
<li><a class="" href="enzymes.html">Enzymes</a></li>
<li><a class="" href="enhancement-media.html">Enhancement Media</a></li>
<li><a class="" href="lectins.html">Lectins</a></li>
<li><a class="" href="adsorptions.html">Adsorptions</a></li>
<li><a class="" href="elutions.html">Elutions</a></li>
<li><a class="" href="titrations-1.html">Titrations</a></li>
<li><a class="" href="cell-separations.html">Cell Separations</a></li>
<li><a class="" href="elisa.html">ELISA</a></li>
<li><a class="" href="molecular-techniques.html">Molecular Techniques</a></li>
<li><a class="" href="neutralization.html">Neutralization</a></li>
<li><a class="" href="thiol-reagents.html">Thiol Reagents</a></li>
<li><a class="" href="immunofluorescence.html">Immunofluorescence</a></li>
<li><a class="" href="solid-phase.html">Solid Phase</a></li>
<li><a class="" href="column-agglutination.html">Column Agglutination</a></li>
<li><a class="" href="chloroquine-diphosphate.html">Chloroquine Diphosphate</a></li>
<li><a class="" href="edta-glycine-acid.html">EDTA-Glycine Acid</a></li>
<li><a class="" href="quality-assurance.html">Quality Assurance</a></li>
<li><a class="" href="blood-samples.html">Blood Samples</a></li>
<li><a class="" href="reagents-1.html">Reagents</a></li>
<li><a class="" href="test-procedures.html">Test Procedures</a></li>
<li class="book-part">Transfusion Practice</li>
<li><a class="" href="indications.html">Indications</a></li>
<li><a class="" href="component-therapy.html">Component Therapy</a></li>
<li><a class="" href="adverse-effects.html">Adverse Effects</a></li>
<li><a class="" href="immunologic.html">Immunologic</a></li>
<li><a class="" href="nonimmunologic.html">Nonimmunologic</a></li>
<li><a class="active" href="ttds.html">TTDs</a></li>
<li><a class="" href="apheresis-extracorporeal-circulation.html">Apheresis &amp; Extracorporeal Circulation</a></li>
<li><a class="" href="blood-administration-patient-blood-management.html">Blood Administration &amp; Patient Blood Management</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="ttds" class="section level1 unnumbered">
<h1>TTDs<a class="anchor" aria-label="anchor" href="#ttds"><i class="fas fa-link"></i></a>
</h1>
<p>While modern blood banking practices have made the blood supply incredibly safe, especially in developed countries, the risk of <strong>Transfusion-Transmitted Diseases (TTDs)</strong>, although very low, can never be completely eliminated. Understanding these risks is crucial for both blood bankers and clinicians</p>
<div id="the-core-concept-infection-via-transfusion" class="section level2 unnumbered">
<h2>
<strong>The Core Concept: Infection via Transfusion</strong><a class="anchor" aria-label="anchor" href="#the-core-concept-infection-via-transfusion"><i class="fas fa-link"></i></a>
</h2>
<p>A TTD occurs when an infectious agent (virus, bacteria, parasite, or prion) present in a donor’s blood is transmitted to a recipient through the transfusion of a blood component</p>
</div>
<div id="why-risk-still-exists-despite-rigorous-testing" class="section level2 unnumbered">
<h2>
<strong>Why Risk Still Exists (Despite Rigorous Testing)</strong><a class="anchor" aria-label="anchor" href="#why-risk-still-exists-despite-rigorous-testing"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>The “Window Period”:</strong> This is the critical time between when a donor becomes infected and when laboratory tests can reliably detect the infection (either the organism’s genetic material or the donor’s antibody response). Modern tests, especially Nucleic Acid Testing (NAT), have dramatically shortened window periods, but they haven’t eliminated them entirely</li>
<li>
<strong>Test Limitations:</strong> No test is 100% sensitive or specific</li>
<li>
<strong>Emerging Pathogens:</strong> New infectious agents may arise for which testing is not yet available</li>
<li>
<strong>Donor Honesty/Recall:</strong> Screening relies on donors accurately reporting potential risk factors</li>
<li>
<strong>Bacterial Contamination:</strong> Can occur during collection or processing, especially for components stored at room temperature (platelets)</li>
<li>
<strong>Human Error:</strong> Although rare, errors in testing or processing could occur</li>
</ul>
</div>
<div id="major-categories-of-transfusion-transmitted-agents" class="section level2 unnumbered">
<h2>
<strong>Major Categories of Transfusion-Transmitted Agents</strong><a class="anchor" aria-label="anchor" href="#major-categories-of-transfusion-transmitted-agents"><i class="fas fa-link"></i></a>
</h2>
<div id="viruses" class="section level3 unnumbered">
<h3>
<strong>Viruses</strong><a class="anchor" aria-label="anchor" href="#viruses"><i class="fas fa-link"></i></a>
</h3>
<p>This group has historically received the most attention and has driven many advances in testing</p>
<ul>
<li>
<strong>Human Immunodeficiency Virus (HIV-1/2)</strong>
<ul>
<li>
<em>Causes:</em> Acquired Immunodeficiency Syndrome (AIDS)</li>
<li>
<em>Risk:</em> Extremely low now (&lt;1 in 2 million in the US) due to donor screening, antibody/antigen testing, and mandatory NAT</li>
<li>
<em>Prevention:</em> Donor questionnaires, deferrals, serologic testing (anti-HIV 1/2 Ab and p24 Ag), and <strong>NAT</strong>
</li>
</ul>
</li>
<li>
<strong>Hepatitis C Virus (HCV)</strong>
<ul>
<li>
<em>Causes:</em> Hepatitis C, leading to chronic liver disease, cirrhosis, and liver cancer</li>
<li>
<em>Risk:</em> Extremely low (&lt;1 in 1.5-2 million)</li>
<li>
<em>Prevention:</em> Donor questionnaires, deferrals, serologic testing (anti-HCV Ab), and <strong>NAT</strong>
</li>
</ul>
</li>
<li>
<strong>Hepatitis B Virus (HBV)</strong>
<ul>
<li>
<em>Causes:</em> Hepatitis B, acute or chronic liver disease, cirrhosis, liver cancer</li>
<li>
<em>Risk:</em> Remains slightly higher than HIV/HCV (~1 in 1 million), partly due to different infection dynamics (e.g., occult HBV)</li>
<li>
<em>Prevention:</em> Donor questionnaires, deferrals, serologic testing (HBsAg - surface antigen, anti-HBc - core antibody), and <strong>NAT</strong>
</li>
</ul>
</li>
<li>
<strong>Human T-Lymphotropic Virus (HTLV-I/II)</strong>
<ul>
<li>
<em>Causes:</em> HTLV-I associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP), Adult T-cell Leukemia/Lymphoma (ATL). HTLV-II less clearly linked to disease</li>
<li>
<em>Risk:</em> Low</li>
<li>
<em>Prevention:</em> Donor questionnaires, serologic testing (anti-HTLV-I/II Ab)</li>
</ul>
</li>
<li>
<strong>Cytomegalovirus (CMV)</strong>
<ul>
<li>
<em>Causes:</em> Usually asymptomatic in healthy individuals but can cause severe disease (pneumonitis, hepatitis, retinitis) in <strong>immunocompromised recipients</strong> (e.g., transplant patients, premature infants)</li>
<li>
<em>Risk:</em> High prevalence in donors (~50-80% are positive). Transmission occurs via leukocytes in cellular components</li>
<li>
<em>Prevention:</em> Providing <strong>CMV-seronegative</strong> units OR <strong>leukoreduced</strong> components (considered CMV-safe equivalent) for at-risk recipients</li>
</ul>
</li>
<li>
<strong>West Nile Virus (WNV)</strong>
<ul>
<li>
<em>Causes:</em> Febrile illness, sometimes neuroinvasive disease (meningitis, encephalitis)</li>
<li>
<em>Risk:</em> Seasonal and geographic variation (mosquito-borne)</li>
<li>
<em>Prevention:</em> <strong>NAT</strong> screening of all donations, especially during peak season</li>
</ul>
</li>
<li>
<strong>Zika Virus</strong>
<ul>
<li>
<em>Causes:</em> Usually mild illness, but significant risk of severe birth defects (microcephaly) if transmitted to pregnant women</li>
<li>
<em>Risk:</em> Geographic variation (mosquito-borne)</li>
<li>
<em>Prevention:</em> Donor questionnaires (travel), deferrals, <strong>NAT</strong> screening (investigational or regional implementation based on risk)</li>
</ul>
</li>
<li>
<strong>Parvovirus B19</strong>
<ul>
<li>
<em>Causes:</em> Fifth disease in children, transient aplastic crisis in patients with hemolytic anemias, potential fetal hydrops in pregnancy</li>
<li>
<em>Risk:</em> Very common virus; high donor prevalence. Not routinely screened. Plasma derivatives undergo viral inactivation steps</li>
<li>
<em>Prevention:</em> Not specifically screened in whole blood/RBCs. Risk mitigation via plasma derivative processing</li>
</ul>
</li>
</ul>
</div>
<div id="bacteria" class="section level3 unnumbered">
<h3>
<strong>Bacteria</strong><a class="anchor" aria-label="anchor" href="#bacteria"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Agent:</strong> Various bacteria, often skin contaminants (<em>Staphylococcus epidermidis, Staphylococcus aureus</em>) or sometimes gut bacteria (<em>Yersinia enterocolitica</em> - associated with RBCs, rare; Gram-negatives in platelets)</li>
<li>
<strong>Disease:</strong> <strong>Transfusion-Associated Sepsis</strong>
</li>
<li>
<strong>Risk:</strong> The <strong>most common infectious risk</strong> in transfusion today, primarily associated with <strong>platelets</strong> stored at room temperature (which supports bacterial growth)</li>
<li>
<strong>Symptoms:</strong> Rapid onset fever, chills/rigors, hypotension/shock during or shortly after transfusion</li>
<li>
<strong>Prevention:</strong> Meticulous arm scrub technique during donation, diversion of initial collection volume, visual inspection of units, <strong>bacterial detection strategies for platelets</strong> (culture, rapid tests)</li>
</ul>
</div>
<div id="parasites" class="section level3 unnumbered">
<h3>
<strong>Parasites</strong><a class="anchor" aria-label="anchor" href="#parasites"><i class="fas fa-link"></i></a>
</h3>
<p>Risk is often geographically dependent</p>
<ul>
<li>
<strong><em>Plasmodium</em> species</strong>
<ul>
<li>
<em>Causes:</em> Malaria</li>
<li>
<em>Risk:</em> Low in non-endemic areas like the US/Canada</li>
<li>
<em>Prevention:</em> Donor screening questionnaires regarding travel to or residence in malaria-endemic areas -&gt; deferral</li>
</ul>
</li>
<li>
<strong><em>Babesia microti</em></strong>
<ul>
<li>
<em>Causes:</em> Babesiosis (tick-borne illness)</li>
<li>
<em>Risk:</em> Increasing, particularly in the Northeastern and Upper Midwestern US</li>
<li>
<em>Prevention:</em> Donor screening questions (history of babesiosis). Laboratory testing (antibody and/or NAT) implemented in endemic areas/states</li>
</ul>
</li>
<li>
<strong><em>Trypanosoma cruzi</em></strong>
<ul>
<li>
<em>Causes:</em> Chagas disease (can lead to chronic heart and GI problems)</li>
<li>
<em>Risk:</em> Primarily donors who lived in endemic areas (Mexico, Central/South America)</li>
<li>
<em>Prevention:</em> Donor screening questions. Routine laboratory testing (antibody) for first-time donors who lived in endemic areas or have other risk factors is standard in the US</li>
</ul>
</li>
</ul>
</div>
<div id="prions" class="section level3 unnumbered">
<h3>
<strong>Prions</strong><a class="anchor" aria-label="anchor" href="#prions"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Agent:</strong> Abnormal prion protein</li>
<li>
<strong>Disease:</strong> Variant Creutzfeldt-Jakob Disease (vCJD) - related to Bovine Spongiform Encephalopathy (“Mad Cow Disease”)</li>
<li>
<strong>Risk:</strong> Extremely low, historically linked to exposure in the UK/Europe</li>
<li>
<strong>Prevention:</strong> <strong>No laboratory screening test.</strong> Prevention relies solely on <strong>donor deferral</strong> based on geographic risk factors (time spent in specific countries during defined periods)</li>
</ul>
</div>
</div>
<div id="multi-layered-safety-approach" class="section level2 unnumbered">
<h2>
<strong>Multi-Layered Safety Approach</strong><a class="anchor" aria-label="anchor" href="#multi-layered-safety-approach"><i class="fas fa-link"></i></a>
</h2>
<p>The safety of the blood supply relies on overlapping strategies:</p>
<ul>
<li>
<strong>Strict Donor Eligibility Criteria:</strong> Based on medical history, travel, and risk behaviors (questionnaire)</li>
<li>
<strong>Donor Deferral Lists:</strong> Maintaining records of ineligible donors</li>
<li>
<strong>Stringent Laboratory Testing:</strong> Using highly sensitive serologic and NAT assays for a panel of required infectious agents</li>
<li>
<strong>Bacterial Detection:</strong> Specific measures for platelet components</li>
<li>
<strong>Component Processing:</strong> Leukoreduction reduces CMV risk</li>
<li>
<strong>Pathogen Reduction Technologies (PRT):</strong> Applied to some plasma and platelet products to inactivate a broad range of pathogens (not yet feasible for RBCs)</li>
<li>
<strong>Appropriate Clinical Use:</strong> Transfusing only when necessary</li>
</ul>
</div>
<div id="key-terms-103" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-103"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Transfusion-Transmitted Disease (TTD):</strong> An infection transmitted from a donor to a recipient via blood component transfusion</li>
<li>
<strong>Window Period:</strong> The time between initial infection of a donor and when laboratory tests can reliably detect that infection</li>
<li>
<strong>Nucleic Acid Testing (NAT):</strong> Highly sensitive molecular tests that detect the genetic material (DNA or RNA) of viruses, significantly shortening the window period compared to antibody tests</li>
<li>
<strong>Serologic Testing:</strong> Laboratory tests that detect antibodies produced by the donor in response to infection or antigens produced by the infectious agent itself</li>
<li>
<strong>Bacterial Contamination / Sepsis:</strong> Presence of bacteria in a blood component leading to a severe systemic infection in the recipient, most commonly associated with room-temperature stored platelets</li>
<li>
<strong>Pathogen Reduction Technology (PRT):</strong> Processes applied to some blood components (plasma, platelets) to inactivate a wide range of viruses, bacteria, and parasites</li>
<li>
<strong>Leukoreduction:</strong> Removal of white blood cells, primarily used to reduce CMV transmission risk (among other benefits)</li>
<li>
<strong>Donor Deferral:</strong> Temporarily or permanently excluding individuals from donating blood based on risk factors identified through screening questionnaires or test results</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
  
  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase" 
          && 
          !elem.classList
          .contains('book-part') 
          ? l.push(elem) 
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="nonimmunologic.html">Nonimmunologic</a></div>
<div class="next"><a href="apheresis-extracorporeal-circulation.html">Apheresis &amp; Extracorporeal Circulation</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#ttds">TTDs</a></li>
<li><a class="nav-link" href="#the-core-concept-infection-via-transfusion">The Core Concept: Infection via Transfusion</a></li>
<li><a class="nav-link" href="#why-risk-still-exists-despite-rigorous-testing">Why Risk Still Exists (Despite Rigorous Testing)</a></li>
<li>
<a class="nav-link" href="#major-categories-of-transfusion-transmitted-agents">Major Categories of Transfusion-Transmitted Agents</a><ul class="nav navbar-nav">
<li><a class="nav-link" href="#viruses">Viruses</a></li>
<li><a class="nav-link" href="#bacteria">Bacteria</a></li>
<li><a class="nav-link" href="#parasites">Parasites</a></li>
<li><a class="nav-link" href="#prions">Prions</a></li>
</ul>
</li>
<li><a class="nav-link" href="#multi-layered-safety-approach">Multi-Layered Safety Approach</a></li>
<li><a class="nav-link" href="#key-terms-103">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/blob/main/Rmd/05-C-03.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/edit/main/Rmd/05-C-03.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-04-07 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
